Pet Safety / Compounds / Camphor

Is Camphor safe for dogs and cats?

Moderate risk for pets

Camphor (1,7,7-trimethylbicyclo[2.2.1]heptan-2-one) is a bicyclic monoterpenoid present in camphor tree (Cinnamomum camphora) and used in topical analgesics (e.g., Vicks VapoRub, Tiger Balm, BenGay), mothball alternatives, pest repellents, and traditional remedies. Dogs are primarily exposed through licking or ingesting camphor-containing topical preparations applied to human skin, chewing camphor balls/blocks, or contacting camphor oil. Dogs absorb camphor efficiently through both oral and dermal routes. CNS toxicity is the primary concern in dogs: camphor stimulates the CNS, producing agitation, muscle tremors, seizures, and in severe cases respiratory depression. Clinical camphor toxicosis in dogs typically follows ingestion of topical formulations (ointments typically contain 4–11% camphor); the threshold for clinical effects is approximately 1–2 mg/kg, and seizures can occur at 5–10 mg/kg. Treatment is symptomatic and supportive; there is no specific antidote. Products containing camphor should be stored securely away from pets, and topical camphor preparations applied to humans should not be shared with or licked by dogs.

What is camphor?

The IUPAC name is 1,7,7-trimethylbicyclo[2.2.1]heptan-2-one.

Also known as: 1,7,7-trimethylbicyclo[2.2.1]heptan-2-one, DL-Camphor, 2-Camphanone, 2-Bornanone.

IUPAC name
1,7,7-trimethylbicyclo[2.2.1]heptan-2-one
CAS number
76-22-2
Molecular formula
C10H16O
Molecular weight
152.23 g/mol
SMILES
CC1(C2CCC1(C(=O)C2)C)C
PubChem CID
2537

Risk for dogs

Moderate risk

Camphor (1,7,7-trimethylbicyclo[2.2.1]heptan-2-one) is a bicyclic monoterpenoid present in camphor tree (Cinnamomum camphora) and used in topical analgesics (e.g., Vicks VapoRub, Tiger Balm, BenGay), mothball alternatives, pest repellents, and traditional remedies. Dogs are primarily exposed through licking or ingesting camphor-containing topical preparations applied to human skin, chewing camphor balls/blocks, or contacting camphor oil. Dogs absorb camphor efficiently through both oral and dermal routes. CNS toxicity is the primary concern in dogs: camphor stimulates the CNS, producing agitation, muscle tremors, seizures, and in severe cases respiratory depression. Clinical camphor toxicosis in dogs typically follows ingestion of topical formulations (ointments typically contain 4–11% camphor); the threshold for clinical effects is approximately 1–2 mg/kg, and seizures can occur at 5–10 mg/kg. Treatment is symptomatic and supportive; there is no specific antidote. Products containing camphor should be stored securely away from pets, and topical camphor preparations applied to humans should not be shared with or licked by dogs.

Risk for cats

Moderate risk

Cats share the CNS sensitivity to camphor seen in dogs and are additionally subject to reduced glucuronidation capacity, which impairs elimination of camphor metabolites. Cats are exposed primarily through grooming — if camphor-containing preparations are applied to a cat's skin or if the cat contacts surfaces where camphor products have been applied, the cat's grooming behavior delivers camphor orally. Camphor in mothball alternatives (camphor balls) presents a distinct hazard; a cat chewing a camphor ball can receive a substantial oral dose. Clinical signs in cats include hypersalivation, ataxia, muscle tremors, and seizures at relatively low doses. The combination of efficient dermal absorption and impaired glucuronidation makes cats potentially more vulnerable to repeated low-level exposures than dogs. Camphor-containing mothballs, cedar oil products with camphor, and some traditional medicine products (tiger balm, red flower oil) are the primary sources of exposure in household settings.

Regulatory consensus

9 regulatory and scientific bodies have classified Camphor. The classifications differ — that's the data.

AgencyYearClassificationNotes
EPA CTX / GenetoxGenotoxicity: positive (Ames: positive, 2 positive / 4 negative reports)
EPA CTX / GenetoxGenotoxicity: positive (Ames: positive, 2 positive / 4 negative reports)
EPA CTX / Skin-EyeEye Irritation: Category 2B (score: moderate)
EPA CTX / Skin-EyeEye Irritation: Category 6.4A (Category 2A) (score: high)
EPA CTX / Skin-EyeSkin Irritation: Category 6.3B (Category 3) (score: moderate)
EPA CTX / Skin-EyeSkin Sensitization: Category 6.5B (Category 1) (score: moderate)
EPA CTX / Skin-Eyeskin sensitisation: in vivo (non-LLNA): Not likely to be sensitizing (score: low)
EPA CTX / Skin-Eyeeye irritation: in vivo: Studies Indicate No Significant Irritation (score: low)
EPA CTX / Skin-Eyeskin irritation: in vivo: Studies Indicate No Significant Irritation (score: low)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where pets encounter camphor

  • Industrial FacilitiesManufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational EnvironmentsFactories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Camphor:

  • Fragrance-free formulations
    Trade-offs: Consumer preference for scented products
    Relative cost: Lower (ingredient elimination)
  • Essential oil-based fragrances (with disclosure)
    Trade-offs: Natural does not mean safe — many essential oils are skin sensitizers
    Relative cost: 2-5× conventional

Frequently asked questions

Is camphor safe for pets?

Camphor (1,7,7-trimethylbicyclo[2.2.1]heptan-2-one) is a bicyclic monoterpenoid present in camphor tree (Cinnamomum camphora) and used in topical analgesics (e.g., Vicks VapoRub, Tiger Balm, BenGay), mothball alternatives, pest repellents, and traditional remedies. Dogs are primarily exposed through licking or ingesting camphor-containing topical preparations applied to human skin, chewing camphor balls/blocks, or contacting camphor oil. Dogs absorb camphor efficiently through both oral and dermal routes. CNS toxicity is the primary concern in dogs: camphor stimulates the CNS, producing agitation, muscle tremors, seizures, and in severe cases respiratory depression. Clinical camphor toxicosis in dogs typically follows ingestion of topical formulations (ointments typically contain 4–11% camphor); the threshold for clinical effects is approximately 1–2 mg/kg, and seizures can occur at 5–10 mg/kg. Treatment is symptomatic and supportive; there is no specific antidote. Products containing camphor should be stored securely away from pets, and topical camphor preparations applied to humans should not be shared with or licked by dogs.

What products contain camphor?

Camphor appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

Why do regulators disagree about camphor?

Camphor has been classified by 9 agencies including EPA CTX / Genetox, EPA CTX / Genetox, EPA CTX / Skin-Eye, EPA CTX / Skin-Eye, EPA CTX / Skin-Eye, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Camphor in the pets app

Look up products containing camphor, compare to alternatives, and explore the full data record.

Open in pets View raw API data

Sources (2)

  1. US FDA: Camphor — OTC External Analgesic Drug Products; Final Monograph (21 CFR 348) and Camphorated Oil Ban (>11%) (1983) — regulatory
  2. ASPCA Animal Poison Control Center: Camphor Toxicosis in Dogs and Cats — Clinical Presentation, Management, and Product Sources (2022) — veterinary

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →